.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Fortis Healthcare reported a robust financial performance for the fourth quarter of FY26, demonstrating strong Fortis Healthcare growth. Specifically, consolidated revenues for the quarter surged by 17.8% to reach ₹2,365 crore. Consequently, operating EBITDA rose 22.2% to ₹531 crore, reflecting healthy clinical demand.
Moreover, the core hospital business served as the primary driver of this financial success. Specifically, hospital revenues rose 19% year-on-year in Q4 FY26 to ₹2,023 crore. Additionally, average revenue per occupied bed (ARPOB) improved to ₹2.56 crore during the fourth quarter. Furthermore, the company observed a significant increase in high-end clinical procedures across key specialties. For instance, robotic surgeries witnessed a massive 66% rise during the fiscal year. In addition, radiation therapy volumes grew by 19%. Consequently, the hospital business expanded its high-margin clinical services.
Importantly, key specialties like cardiac sciences, orthopedics, neurology, gastroenterology, oncology, and renal sciences contributed 62% to total revenues. In particular, renal sciences and orthopedics emerged as key growth areas, recording 22% and 21% growth respectively. Meanwhile, Fortis strengthened its clinical network by adding nearly 500 beds through strategic acquisitions. These acquisitions included People Tree Hospital in Bengaluru and Shrimann Hospital in Jalandhar. Additionally, the company secured a long-term lease for Greater Noida Hospital. Alongside this, the diagnostics business under Agilus Diagnostics delivered steady growth. Specifically, gross revenues for the diagnostics arm increased 11.1% to ₹387 crore in Q4 FY26.
Q1: What was the net profit growth of Fortis Healthcare in Q4 FY26?
Fortis Healthcare reported a 44.2% jump in profit after tax to ₹271 crore for the fourth quarter ended March 31, 2026, compared to ₹188 crore in the corresponding quarter of the previous year.
Q2: Which medical specialties drove the revenue growth for Fortis Healthcare?
The top six specialties—including cardiac sciences, orthopedics, neurology, gastroenterology, oncology, and renal sciences—contributed nearly 62% of total hospital revenues, with renal sciences and orthopedics showing the fastest growth.
Q3: How did the diagnostics business perform during the quarter?
Agilus Diagnostics reported an 11.1% year-on-year increase in gross revenues to ₹387 crore in Q4 FY26, supported by robust preventive testing volumes.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Fortis Healthcare reports a 44% jump in Q4 profit to ₹271 crore, driven by strong hospital business performance and specialty care expansion in FY26....
3 months ago
Integrating prompt medical nutrition therapy into ICU protocols prevents muscle wasting, decreases secondary infections, and accelerates recovery. Leading intensivists urge healthcare teams to treat targeted feeding as an indispensable therapy that curbs downstream hospitalization expenses.
Today
A multicentre RCT in China shows that the PAICS AI system significantly boosts sonographer sensitivity in detecting fetal intracranial malformations by 8.7% without compromising specificity, offering promising diagnostic support for prenatal neurosonography.
Today
A recent study highlights the utility of two-dimensional speckle tracking echocardiography in assessing right atrial mechanics in OSAHS. Progressive reductions in reservoir and conduit strain, coupled with elevated contraction strain, signal early right heart remodeling correlated with apnea severity.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Yesterday
A propensity-matched study shows ultrasound-guided pulsed radiofrequency of the lumbar sympathetic ganglion is non-inferior to fluoroscopy for painful diabetic neuropathy, reducing needle passes, procedure time, and radiation exposure while achieving equal pain relief.
Today
